Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dengue Virus | 2 | 2020 | 201 | 0.740 |
Why?
|
TRPV Cation Channels | 2 | 2018 | 243 | 0.630 |
Why?
|
Phosphatidylinositols | 1 | 2019 | 282 | 0.620 |
Why?
|
Arachidonic Acids | 1 | 2017 | 294 | 0.550 |
Why?
|
Dengue | 1 | 2019 | 254 | 0.540 |
Why?
|
Bacillus | 1 | 2016 | 78 | 0.510 |
Why?
|
Ear Diseases | 1 | 2017 | 180 | 0.500 |
Why?
|
Antiviral Agents | 12 | 2024 | 3037 | 0.480 |
Why?
|
Triazines | 4 | 2024 | 311 | 0.470 |
Why?
|
Edema | 1 | 2017 | 765 | 0.420 |
Why?
|
Fatty Acids | 1 | 2016 | 1808 | 0.300 |
Why?
|
Indazoles | 3 | 2024 | 304 | 0.300 |
Why?
|
Serine Endopeptidases | 3 | 2021 | 1022 | 0.290 |
Why?
|
Virus Replication | 4 | 2022 | 2427 | 0.250 |
Why?
|
Triazoles | 3 | 2024 | 903 | 0.230 |
Why?
|
Dibenzothiepins | 1 | 2022 | 8 | 0.200 |
Why?
|
Drugs, Chinese Herbal | 1 | 2024 | 144 | 0.200 |
Why?
|
Chemokines | 3 | 2022 | 954 | 0.200 |
Why?
|
Coenzyme A Ligases | 1 | 2021 | 45 | 0.200 |
Why?
|
Morpholines | 2 | 2022 | 581 | 0.190 |
Why?
|
Serine Proteases | 1 | 2021 | 50 | 0.180 |
Why?
|
Linoleic Acid | 1 | 2021 | 158 | 0.180 |
Why?
|
Ceramides | 1 | 2021 | 200 | 0.180 |
Why?
|
Macrophages | 3 | 2019 | 5758 | 0.160 |
Why?
|
Orthomyxoviridae Infections | 1 | 2022 | 254 | 0.160 |
Why?
|
Hep G2 Cells | 1 | 2019 | 378 | 0.160 |
Why?
|
Influenza A virus | 1 | 2022 | 458 | 0.150 |
Why?
|
Interferon-beta | 1 | 2019 | 345 | 0.150 |
Why?
|
Lipoxygenase | 1 | 2017 | 72 | 0.140 |
Why?
|
Epidemics | 1 | 2023 | 512 | 0.140 |
Why?
|
Quinolones | 1 | 2020 | 378 | 0.140 |
Why?
|
Transferases (Other Substituted Phosphate Groups) | 1 | 2016 | 36 | 0.140 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 321 | 0.140 |
Why?
|
Synovial Fluid | 1 | 2019 | 393 | 0.140 |
Why?
|
Mice, Inbred ICR | 1 | 2017 | 364 | 0.140 |
Why?
|
Sphingomyelins | 1 | 2016 | 105 | 0.130 |
Why?
|
Pyridones | 1 | 2022 | 808 | 0.130 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2017 | 318 | 0.130 |
Why?
|
Vero Cells | 3 | 2021 | 481 | 0.130 |
Why?
|
Arthritis, Experimental | 1 | 2018 | 291 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2022 | 983 | 0.120 |
Why?
|
Protease Inhibitors | 3 | 2023 | 753 | 0.120 |
Why?
|
Th1 Cells | 1 | 2019 | 1027 | 0.120 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1662 | 0.110 |
Why?
|
Macrophage Activation | 1 | 2016 | 552 | 0.110 |
Why?
|
Cytokines | 4 | 2022 | 7373 | 0.110 |
Why?
|
Drug Discovery | 1 | 2021 | 1051 | 0.110 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22117 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1936 | 0.100 |
Why?
|
Animals | 14 | 2022 | 168202 | 0.090 |
Why?
|
Osteoarthritis | 1 | 2018 | 1063 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3149 | 0.090 |
Why?
|
Oxidation-Reduction | 1 | 2016 | 2231 | 0.080 |
Why?
|
Iodoacetic Acid | 2 | 2019 | 11 | 0.080 |
Why?
|
Japan | 2 | 2024 | 1372 | 0.080 |
Why?
|
Osteoarthritis, Knee | 1 | 2019 | 1234 | 0.080 |
Why?
|
Mice, Knockout | 2 | 2021 | 14388 | 0.080 |
Why?
|
Inflammation | 2 | 2019 | 10759 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1884 | 0.070 |
Why?
|
Pain | 2 | 2019 | 5062 | 0.070 |
Why?
|
Cell Line | 4 | 2021 | 15577 | 0.070 |
Why?
|
Hand Strength | 2 | 2019 | 456 | 0.060 |
Why?
|
Lung | 3 | 2022 | 9999 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2024 | 12333 | 0.060 |
Why?
|
Models, Biological | 1 | 2021 | 9461 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2021 | 7847 | 0.060 |
Why?
|
Mice | 6 | 2022 | 81368 | 0.060 |
Why?
|
Vietnam | 1 | 2024 | 406 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2024 | 131 | 0.050 |
Why?
|
RNA, Viral | 2 | 2022 | 2838 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16968 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2019 | 11512 | 0.050 |
Why?
|
Republic of Korea | 1 | 2024 | 583 | 0.050 |
Why?
|
Oseltamivir | 1 | 2022 | 75 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4269 | 0.050 |
Why?
|
Furin | 1 | 2021 | 46 | 0.050 |
Why?
|
Serial Passage | 1 | 2021 | 23 | 0.050 |
Why?
|
Viral Nonstructural Proteins | 1 | 2023 | 227 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 240 | 0.050 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2022 | 113 | 0.050 |
Why?
|
Viral Tropism | 1 | 2021 | 102 | 0.040 |
Why?
|
Vaccines, Attenuated | 1 | 2021 | 315 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2021 | 363 | 0.040 |
Why?
|
Humans | 16 | 2024 | 760740 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2021 | 363 | 0.040 |
Why?
|
Cross Reactions | 1 | 2021 | 816 | 0.040 |
Why?
|
Male | 8 | 2024 | 360402 | 0.040 |
Why?
|
Cricetinae | 1 | 2023 | 2424 | 0.040 |
Why?
|
Ribavirin | 1 | 2020 | 392 | 0.040 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2019 | 174 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2020 | 348 | 0.040 |
Why?
|
Pain Measurement | 2 | 2019 | 3546 | 0.040 |
Why?
|
Nerve Growth Factor | 1 | 2019 | 158 | 0.040 |
Why?
|
Methyltransferases | 1 | 2020 | 373 | 0.040 |
Why?
|
Virulence | 1 | 2021 | 1299 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2019 | 8165 | 0.040 |
Why?
|
Virus Internalization | 1 | 2021 | 497 | 0.040 |
Why?
|
Leucine | 1 | 2018 | 548 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 596 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2021 | 2178 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18220 | 0.030 |
Why?
|
Weight-Bearing | 1 | 2019 | 532 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 597 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1739 | 0.030 |
Why?
|
Ganglia, Spinal | 1 | 2018 | 525 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1788 | 0.030 |
Why?
|
Molecular Weight | 1 | 2016 | 2185 | 0.030 |
Why?
|
Triglycerides | 1 | 2021 | 2459 | 0.030 |
Why?
|
Viral Proteins | 1 | 2021 | 1799 | 0.030 |
Why?
|
Female | 6 | 2024 | 392203 | 0.030 |
Why?
|
Viral Load | 1 | 2023 | 3325 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 18937 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2024 | 64572 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2022 | 6188 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4117 | 0.030 |
Why?
|
Rats | 2 | 2019 | 23716 | 0.030 |
Why?
|
Adult | 5 | 2024 | 220995 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2022 | 3705 | 0.020 |
Why?
|
Pyrroles | 1 | 2018 | 1125 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2022 | 6305 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2682 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5780 | 0.020 |
Why?
|
Pneumonia | 1 | 2022 | 2143 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13442 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5863 | 0.020 |
Why?
|
Sulfonamides | 1 | 2018 | 1977 | 0.020 |
Why?
|
Skin | 1 | 2021 | 4472 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2016 | 1589 | 0.020 |
Why?
|
Young Adult | 2 | 2024 | 59191 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8311 | 0.020 |
Why?
|
Mutation | 2 | 2021 | 30015 | 0.020 |
Why?
|
Middle Aged | 3 | 2024 | 220603 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8542 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2019 | 12759 | 0.010 |
Why?
|
Aged | 2 | 2024 | 169092 | 0.010 |
Why?
|
Neurons | 1 | 2018 | 9436 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54364 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74128 | 0.010 |
Why?
|
Child | 1 | 2024 | 80089 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 88247 | 0.010 |
Why?
|
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_